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Abstract
Complexation-mediated  electromembrane  extraction  (EME)  of  highly
polar basic drugs (log P < −1) was investigated for the first time with the
catecholamines  epinephrine,  norepinephrine,  and  dopamine  as  model
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analytes.  The  model  analytes  were  extracted  as  cationic  species  from
urine  samples  (pH  4),  through  a  supported  liquid  membrane  (SLM)
comprising  25  mM 4-(trifluoromethyl)phenylboronic  acid  (TFPBA)  in
bis(2-ethylhexyl)  phosphite  (DEHPi),  and  into  20  mM formic  acid  as
acceptor solution. EME was performed for 15 min, and 50 V was used as
extraction  voltage  across  the  SLM.  TFPBA  served  as  complexation
reagent,  and  selectively  formed boronate  esters  by  reversible  covalent
binding  with  the  model  analytes  at  the  sample/SLM  interface.  This
enhanced the mass transfer of the highly polar model analytes across the
SLM, and EME of basic drugs with log P  in  the  range −1 to  −2 was
shown for the first time. Meanwhile, most matrix components in urine
were  unable  to  pass  the  SLM.  Thus,  the  proposed  concept  provided
highly efficient sample clean-up and the system current across the SLM
was  kept  below  50  µA.  Finally,  the  complexation-mediated  EME
concept  was  combined  with  ultra-high  performance  liquid
chromatography coupled to tandem mass spectrometry and evaluated for
quantification  of  epinephrine  and  dopamine.  Standard  addition
calibration  was  applied  to  a  pooled  human  urine  sample.  Calibration
curves using standards between 25 and 125 µg L  gave a high level of
linearity  with  a  correlation  coefficient  of  0.990  for  epinephrine  and
0.996 for dopamine (N = 5). The limit of detection, calculated as three
times  signal-to-noise  ratio,  was  5.0  µg  L  for  epinephrine  and
1.8 µg L  for dopamine. The repeatability of the method, expressed as
coefficient  of  variation,  was  13% (n  =  5).  The  proposed  method  was
finally  applied for  the  analysis  of  spiked pooled human urine  sample,
obtaining  relative  recoveries  of  91  and  117%  for  epinephrine  and
dopamine, respectively.
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Introduction
Electromembrane extraction (EME) is a miniaturized extraction technique
evolved from hollow fiber liquid-phase microextraction (HF-LPME) [1]. In
EME, charged analytes are extracted from aqueous sample, through an
organic solvent immobilized as a supported liquid membrane (SLM) in the
pores of a polymeric hollow fiber, and into an acceptor solution located in
the lumen of the fiber [2]. An electrical potential difference is employed as
driving force for the electrokinetic migration of analytes across the SLM.
A power supply provides a DC potential between two electrodes placed in
the sample and acceptor solution, respectively. For the extraction of basic
analytes, the anode (positively charged electrode) is placed into sample
whereas the cathode (negatively charge electrode) is placed into the
acceptor solution. For the extraction of acidic analytes, the direction of the
electrical field is reversed, the cathode is located in the sample and the
anode is located in the acceptor solution. The pH of both sample and
acceptor solution has to be controlled to ensure full ionization of the target
analytes. Major advantages of EME include the following[3, 4]: low
consumption of organic solvents; shorter extraction times than HF-LPME
due to the enhancement of mass transport by the force of the electrical
potential; efficient sample clean-up and feasibility of direct extraction from
untreated complex matrices; easy extraction selectivity modulation by
changes in the magnitude and direction of the electrical potential; high
preconcentration capacity; direct compatibility with a wide range of
analytical instruments; simple and low cost equipment; and possibilities of
downscaled format (i.e., microchip devices) and automation.
Experimental parameters such as the SLM composition, extraction voltage,
extraction time, pH of sample and acceptor solutions, salt effect, and
sample stirring speed strongly affect EME performance, and are normally
optimized in different applications [2, 3]. The selection of appropriate
solvent within the pores of the fiber is a critical task of the technique.
Some important properties of the solvent to consider are immiscibility with
water to prevent losses by dissolution, low volatility to avoid evaporation
during extraction, low viscosity to ensure high diffusion coefficients across
SLM, good extractability and high partition coefficient of the target
analytes, and certain dipole moment or conductivity to support current
flow in the system [3, 5]. For the EME of non-polar (log P > 2) basic
drugs, 2-nitrophenyl octylether (NPOE) [6, 7, 8, 9, 10, 11, 12, 13, 14] has
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been the most employed solvent, although 1-ethyl-2-nitrobenzene (ENB)
[15, 16, 17, 18] and 1-isopropyl-4-nitrobenzene (IPNB) [19, 20] have been
alternatively proposed, performing extractions at low voltages. NPOE,
ENB, and IPNB possess low water solubility, high boiling point, and are
able to form dipole-dipole and hydrogen bonding interactions with
positively charged analytes, thus being suitable solvents to create efficient
SLMs [20, 21]. The extraction of polar (log P < 2) basic drugs is more
challenging since these species are less prone to cross the hydrophobic
SLM under the influence of an electrical field. In this case, the presence of
carriers in the SLM is compulsory to promote the analyte transfer and to
increase EME efficiency. Among tested carriers, di(2-ethylhexyl)
phosphate (DEHP) and tri(2-ethylhexyl) phosphate (TEHP) have been the
most popular ones [21]. DEHP forms ion-pairs with positively charged
basic drugs, whereas TEHP is a non-ionic carrier interacting with charged
analytes mainly by dipole-dipole and hydrogen interactions. DEHP has
been more efficient than TEHP for the extraction of the most polar basic
drugs (0.01 < log P < 1.8) [21]. However, DEHP suffers from some
drawbacks related to the increase of the electrical conductance of the SLM
and extraction of background electrolyte ions and other ionic sample
components, leading to high system currents [22]. Very recently, a new
SLM based on bis(2-ethylhexyl) phosphite (DEHPi) has been discovered as
a good candidate for the extraction of polar (log P values between −0.40
and 1.32) basic analytes from plasma samples [22]. DEHPi was compared
with SLMs based on DEHP and TEHP, and DEHPi provided lower currents
and higher system stability [22].
Experiences with EME of basic drug substances of very high polarity
(−1 > log P > −2) have not yet been reported in the literature, and therefore
a fundamental study on this was addressed in the present work. The
catecholamines dopamine (DA) (log P = −0.99), epinephrine (E) (log
P = −1.37), and norepinephrine (NE) (log P = −1.85) were selected as
model analytes [23]. In order to enhance their mass transfer across the
SLM, and to maintain an acceptable level of selectivity and sample
clean-up from biological fluids, different analogues of phenylboronic acid
(PBA) were added to the EME system as selective complexation reagents
for the catecholamines. Operational parameters for this conceptually new
type of complexation-mediated EME system were studied and optimized to
obtain fundamental experience and knowledge. Special emphasis was
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devoted to recovery, current stability, and sample clean-up. The optimized
EME system was finally combined with ultra-high performance liquid
chromatography coupled to tandem mass spectrometry (UHPLC-MS/MS),
and evaluated for the quantification of DA and E in human urine.
Experimental part
Chemicals
Dopamine hydrochloride, epinephrine hydrochloride, norepinephrine
bitartrate, 1,4-benzodioxane-6-boronic acid,
4-(trifluoromethyl)phenylboronic acid (TFPBA), m-tolylboronic acid,
4-(benzyloxy)phenylboronic acid, 4-(dimethylamino)phenylboronic acid,
4-(trans-2-carboxyvinyl)phenylboronic acid, DEHP, DEHPi, formic acid,
and sodium 1-heptanesulfonate were all purchased from Sigma-Aldrich
(St. Louis, MO, USA). PBA and NPOE were obtained from Fluka (Buchs,
Switzerland). Hydrochloric acid, phosphoric acid, sodium dihydrogen
phosphate monohydrate, disodium hydrogen phosphate dodecahydrate,
trisodium phosphate dodecahydrate, and methanol were supplied by Merck
(Darmstadt, Germany). The ultrapure water (resistivity of 18.2 MΩ cm at
25 °C) employed for preparing aqueous solutions was obtained with a
Milli-Q water purification system (Molsheim, France).
Solutions and urine samples
Stock solutions of E, NE, and DA were prepared at 1000 mg L  in
methanol and stored at 5 °C protected from light. Aqueous working
solutions were daily prepared by proper dilution of stock solutions with
selected background electrolyte (i.e., 10 mM hydrochloric acid or 20 mM
phosphate buffer). Solutions of 1 mg L  containing the three analytes
were employed in initial experiments and EME optimization.
Urine samples were collected from healthy volunteers in sterilized
containers and kept at 5 °C before analysis. Urine samples were diluted
with 20 mM phosphate buffer of predetermined pH (volume ratio 1:1)
before EME experiments.
Instrumentation
Two chromatographic systems were employed for EME optimization and
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method evaluation, respectively. For EME optimization, chromatographic
analysis was performed by high performance liquid chromatography
coupled to ultraviolet detection (HPLC-UV). The chromatographic system
containing a degasser, a binary pump, and an autosampler (all of 1200
series) was from Agilent Technologies (Santa Clara, CA, USA). Gemini
C18 column (150 mm × 2 mm I.D, 5 µm particle size) from Phenomenex
(Torrance, CA, USA) was employed for separation. The injection volume
was 10 µL. Analytes were eluted in gradient mode using mobile phases A
and B. Mobile phase A consisted of 95% water phase (20 mM formic acid
and 5 mM sodium 1-heptanesulfonate in ultrapure water) and 5%
methanol. Mobile phase B consisted of 95% methanol and 5% water phase
(20 mM formic acid and 5 mM sodium 1-heptanesulfonate in ultrapure
water). Elution program was as follows: mobile phase B was increased
from 3 to 35% within 12 min. Then, mobile phase B was further increased
to 80% in 0.5 min and this condition was kept for 3.5 min. Finally, the
mobile phase composition was returned to the starting conditions and held
constant for 4 min before next injection. The total analysis time was
20 min with a flow rate of 0.4 mL min . The UV detector was set at
280 nm.
Method evaluation was carried out using UHPLC-MS/MS. The
chromatographic system comprised a Dionex UltiMate 3000 RS pump,
autosampler, and column compartment followed by a LTQ XL linear ion
trap mass spectrometer from Thermo Scientific (San Jose, CA, USA).
Chromatographic separation was achieved on an Acquity UPLC® HSS T3
column (100 mm × 2.1 mm I.D, 1.8 µm particle size) from Waters
(Wexford, Ireland) kept at 40 °C. The injection volume was 5 µL. Mobile
phase A contained 95% water phase (20 mM formic acid in ultrapure
water) and 5% methanol. Mobile phase B contained 95% methanol and 5%
water phase (20 mM formic acid in ultrapure water). The linear gradient
elution was programmed from 1 to 80% of mobile phase B in 1.5 min.
Eighty percent of mobile phase B was kept for 1 min before changing back
to the starting conditions for equilibration. The total analysis time was
5.5 min with a flow rate of 0.3 mL min . MS/MS detection was acquired
in the selected reaction monitoring (SRM) mode with electrospray
ionization in the positive mode. Transitions (m/z) 184➔166 and 154➔137
were monitored for E and DA, respectively, for quantitative purposes. NE
was excluded from the method evaluation in this conceptual work (i.e.,
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UHPLC-MS/MS) since its quantification in the concentration range of
interest (i.e., µg L  level) was not achieved. The source fragmentation
energy was 35 V and the collision energy was 15% for E and 17% for DA.
EME set-up and procedure
The sample compartment was a 2-mL glass vial with screw cap from
Supelco (Bellefonte, PA, USA). The hollow fiber used as the support for
the organic solvent and for housing the acceptor solution was a PP Q3/2
polypropylene hollow fiber from Membrana (Wuppertal, Germany) with an
internal diameter of 1.2 mm, wall thickness of 200 µm, and pore size of
0.2 µm. A Thermomixer Comfort agitator from Eppendorf (Hamburg,
Germany) was used to agitate the extraction unit during EME. Platinum
wires with 0.5 mm of diameter were used as electrodes. The electric
potential was generated by a DC power supply (model ES 0300-0.45) from
Delta Electronika (Zierikzee, The Netherlands). Current was monitored
during EME using an Agilent U1253B True Rms Oled multimeter.
EME was performed according to the following procedure: 1 mL of sample
solution was placed into 2 mL glass vial. The polypropylene hollow fiber
was cut in a 2.5-cm piece whose lower end was sealed by mechanical
pressure. The upper end was connected by heat to a 2.2-cm length pipette
tip (Finntip 200 Ext from Thermo Scientific) acting as guiding tube. The
hollow fiber was dipped for 5 s in the organic solvent used as SLM and the
excess of solvent was thereafter removed with a medical wipe. Via guiding
tube, 25 µL of acceptor solution was filled into the lumen of the hollow
fiber with a microsyringe. Subsequently, the hollow fiber was inserted
through the vial cap and introduced in the sample. Finally, the cathode was
placed in the acceptor solution and the anode in the sample. The electrodes
were connected to the power supply and the extraction unit was agitated at
900 rpm for a predetermined time. After EME, acceptor solution was
collected with a microsyringe for its final injection in the corresponding
chromatographic system (i.e., HPLC-UV for optimization studies and
UHPLC-MS/MS to evaluate the method).
Calculations
The EME recovery was calculated using the following equation:
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where C  is the final concentration of the analyte in the acceptor solution,
C  is the initial analyte concentration in the sample solution, V  is the
volume of the acceptor solution, and V  is the volume of the sample.
Results and discussion
Experiments based on conventional EME
First, experiments were performed using pure NPOE as SLM. The
catecholamines were dissolved in 10 mM hydrochloric acid (pH 2), and
this solution served as sample. EME was operated at 300 V. After 5 min of
extraction, no analytes were detected by HPLC-UV in the acceptor
solution. The catecholamines were then dissolved in 20 mM phosphate
buffer (pH 5), and with this solution serving as sample, EME was repeated
under equal conditions. However, also in this case, no extraction of the
catecholamines was observed. The inefficiency of NPOE was expected.
NPOE is well known to efficiently extract non-polar basic compounds (log
P ˃ 2) by strong dipole and hydrogen bonding interactions. On the other
hand, the extraction of polar analytes with low affinity to the SLM
generally requires the use of hydrophobic ion-pair reagents, such as DEHP,
acting as carriers [21].
DEHP has been frequently combined with NPOE for the extraction of polar
substances, since its ability to form complexes with positively charged
species facilitates their transfer into the SLM [21]. A SLM based on NPOE
with 10% (w/w) of DEHP was tested for the catecholamines using an
extraction voltage of 25 V. Standard solutions of pH 2 and 5 (10 mM
HClhydrochloric acid and 20 mM phosphate buffer, respectively) were
subjected to EME for 5 min. Surprisingly, the analytes were not found in
the corresponding acceptor solutions, even not at trace level. Thus, the
SLM comprising a mixture of DEHP and NPOE appeared to be insufficient
for mass transfer of the highly polar catecholamines.
DEHPi has been recently demonstrated as SLM for extraction of polar
basic drugs in the log P range from −0.40 to 1.32 [22]. DEHPi was also
tested in the current work for catecholamines using an applied voltage of
Recovery (%) = × 100CaVaCsVs
a
s a
s
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50 V. After 5 min of extraction from an aqueous standard solution of pH 2
(10 mM HClhydrochloric acid), catecholamines were now detected in the
acceptor solution. The extraction recoveries were 0.3% for E, 0.4% for NE,
and 0.8% for DA. The experiment was repeated with 10 min extraction
time, and extraction recoveries increase to 0.5% for E, 0.7% for NE, and
1.6% for DA. However, a more significant improvement was observed
using a standard solution of pH 5 (20 mM phosphate buffer), and
recoveries were now 3% for E, 6% for NE, and 14% for DA after 10 min
of extraction. The pH dependence observed was unexpected since DEHPi
is not able to form ionic interactions under normal pH conditions [22]. The
enhancement in extraction performance at higher pH was hypothesized to
be due to the presence of small amounts of ionic oxidation products in
DEHPi. Thus, special attention should be paid in the manipulation of
DEHPi, using closed containers to avoid its progressive oxidation as far as
possible.
Experiments based on complexation-mediated EME
The molecular structures of the catecholamines include two phenolic
groups in ortho position as a common feature. PBA and derivatives possess
a high affinity to complex these phenols, forming boronate esters by
reversible covalent binding (Fig. 1). Based on this type of complexation,
previous publications [24, 25, 26] have reported the ability of PBA
derivatives to facilitate transport of diol containing species (e.g., DA,
glucoside, fructose) through SLMs under passive diffusion conditions. This
concept was transferred to EME in the present work, and tested under
electrokinetic migration conditions. The idea was to enhance the mass
transfer of catecholamines due to selective complexation, while
suppressing the general mass transfer of cationic matrix components.
Fig. 1
PBA complexation of diol groups
In a first experiment, PBA was dissolved in standard solution of pH 5 at a
concentration of 5 mM. EME was performed for 10 min at 50 V using
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DEHPi as SLM. Under these conditions, recoveries were 4% for E, 10%
for NE, and 20% for DA. The improvement in extraction efficiency,
especially for NE and DA, was attributed to decreased polarity of these
molecules via complexation (Fig. 1). Based on this positive finding, the
potential for complexation-mediated EME was studied in more detail
below.
Optimization
Type of complexing reagent
PBA and six different derivatives (namely 1,4-benzodioxane-6-boronic
acid; TFPBA; m-tolylboronic acid; 4-(benzyloxy)phenylboronic acid;
4-(dimethylamino) phenylboronic acid; and 4-(trans-
2-carboxyvinyl)phenylboronic acid) were investigated using DEHPi as
SLM. For stepwise development of experiences, optimization was
performed with aqueous standard solutions. The complexing reagents were
dissolved in the sample solution or in DEHPi depending on their polarity
and water miscibility. Thus, PBA (log P = 1.64) and 1,4-benzodioxane-
6-boronic acid (log P = 0.95) were added to the aqueous sample, and with
these reagents complexation was expected in the bulk sample. In contrast,
TFPBA (log P = 2.52), m-tolylboronic acid (log P = 2.11), and
4-(benzyloxy)-phenylboronic acid (log P = 3.16) were dissolved in the
SLM. With these reagents, complexation was expected at the sample/SLM
interface. The use of equal amounts (moles) of the different reagents was
considered necessary in order to compare their net effect on EME.
Therefore, reagents in the aqueous standard (1 mL) were dissolved at a
concentration of 1 mM, whereas reagents in the SLM (approximately
20 µL) were dissolved at a concentration of 50 mM. The dissolution of
4-(dimethylamino)phenylboronic acid (log P = 1.90) and 4-(trans-
2-carboxyvinyl)phenylboronic acid (log P = 1.99) in aqueous phase or
DEHPi was not achieved at selected concentrations, and these derivatives
were therefore discarded. The effect of the different complexing reagents
on EME of catecholamines is shown in Fig. 2. As observed, higher
recoveries were obtained with TFPBA dissolved in DEHPi, and therefore
this reagent was selected for further investigations together with PBA.
TFPBA and PBA were both tested with NPOE as SLM, but these EME
systems were not efficient. Thus, DEHPi was used as SLM in all remaining
experiments.
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Fig. 2
Effect  of  complexing  reagent.  Extraction  conditions:  concentration  of
analytes,  1  mg L ;  sample  pH,  5;  SLM,  DEHPi;  applied  voltage,  50  V;
extraction time, 10 min; acceptor solution, 20 mM formic acid. Error bars
represent the standard deviation of three replicated analysis
Concentration of complexing reagent
Different concentrations of PBA in the sample solution (i.e., 0, 0.5, 1, 3, 5,
and 10 mM) and TFPBA in SLM (i.e., 0, 25, 50, and 250 mM) were
evaluated. As shown in Fig. 3a, the effect of PBA on EME performance
was practically negligible at concentrations of 0.5 and 1 mM. In these
experiments, the molar concentration of PBA was 30–60 times higher than
the analyte concentrations used in the experiment (1 mg L ). However, a
significant increase in extraction was observed at 3, 5, and 10 mM,
especially for NE and DA. System current measurements revealed that
current increased with PBA concentration, although it was kept below
50 µA in all cases [22]. Finally, 3 mM PBA was selected as optimum value
since extraction recoveries were comparable to those obtained at higher
concentrations (i.e., 5 and 10 mM), but the EME system was more stable.
Regarding TFPBA, Fig. 3b shows an enhancement in extraction
performance as the reagent concentration increased. However, as observed
with PBA, the system current increased with the concentration of the
complexing reagent exceeding 50 µA at 250 mM. Finally, 25 mM TFPBA
was selected as a compromise value.
Fig. 3
Effect  of  a  PBA  concentration,  and  b  TFPBA  concentration.  Extraction
conditions:  concentration  of  analytes,  1  mg  L ;  sample  pH,  5;  SLM,
−1
−1
−1
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DEHPi; applied voltage, 50 V; extraction time, 10 min; acceptor solution,
20 mM formic  acid.  Error  bars  represent  the  standard  deviation  of  three
replicated analysis
The EME of catecholamines using simultaneously 3 mM PBA dissolved in
sample solution (i.e., aqueous standard) and 25 mM TFPBA dissolved in
DEHPi was also tested. Recoveries were not significantly different to those
obtained with complexing reagents separately and system current
increased. Therefore, the simultaneous use of PBA and TFPBA was
discarded.
Finally, selected optimum conditions (i.e., 3 mM PBA or 25 mM TFPBA
dissolved in sample solution or DEHPi, respectively) were evaluated in a
real urine sample diluted with 20 mM phosphate buffer pH 5 (volume ratio
1:1). Higher recoveries were obtained with 25 mM TFPBA (see Electronic
Supplementary Material (ESM) Fig. S1). Additionally, a general increase
in system current was observed when EME was conducted from the real
samples compared to aqueous standards. However, the increase in current
was lower and kept below 50 µA for TFPBA. According to these results,
TFPBA was finally selected as complexing reagent for EME of the
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catecholamines.
Sample pH and acceptor solution composition
The effect of sample pH on EME was investigated in the range of pH 3–8
using 20 mM phosphate buffer solutions. As shown in Fig. S2 (see ESM),
extraction recoveries were lower at pH 3 and 8 whereas comparable values
were obtained for pH 4, 5, 6, and 7. The drop in extraction efficiency at
pH 3 could be related to a reduced affinity of TFPBA to complex target
analytes under strongly acidic conditions. The drop in extraction efficiency
at pH 8 could be due to a partial negative ionization of the target analytes
and, most likely, to the formation of anionic complexes with TFPBA [27].
Boronic acids can form neutral esters in non-polar solvents whereas they
tend to form anionic boronate esters in water at basic pH [27]. At pH 8, the
formation of anionic complexes could be favored over the formation of
neutral complexes. The transport of these negatively charged molecules
through the SLM was hindered by the direction of the applied voltage, and
thus, the extraction efficiency decreased.
Finally, pH 4 was selected as optimum value in terms of recoveries, and
also considering the higher stability of the target analytes under acidic
conditions [23].
The effect of acceptor solution composition on complexation-mediated
EME was evaluated employing acidic conditions to maintain the positive
ionization of catecholamines. To this end, solutions of 20 mM formic acid
(pH = 2.7), 200 mM formic acid (pH = 2.2), 20 mM phosphate buffer
(pH = 2), and 10 mM hydrochloric acid (pH = 2) were prepared and used
as acceptor solution in different experiments. EME was performed from
pH 4 sample solution, using DEHPi with 25 mM TFPBA in the SLM and
an applied voltage of 50 V. After 10 min of extraction, comparable
extraction efficiencies (data not shown) were obtained with the different
experiments, showing a negligible effect of the acceptor solution
composition on the EME. Finally, 20 mM formic acid was selected in
subsequent experiments considering its compatibility with the
UHPLC-MS/MS system use to evaluate the method.
Applied voltage and extraction time
The influence of applied voltage was studied from 0 to 100 V. In
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experiments at 0 V, catecholamines were not found in acceptor solution,
and this supported that there were no passive diffusion of the model
analytes in the current complexation-mediated EME systems. Thus, the use
of voltage across the SLM was required to extract highly polar target
analytes. The effect of voltage on complexation-mediated EME is shown in
Fig. 4a. As expected, the extraction recoveries increased with increasing
voltage up to 100 V. However, system current also increased with the
applied voltage, and the current exceeded 50 µA at 75 and 100 V. For urine
samples, system current was also expected to exceed 50 µA at 75 and
100 V and it was checked to be under this value at 50 V. Finally, 50 V was
chosen as optimum extraction voltage, compromising extraction recovery
and EME system stability (current below 50 µA).
Fig. 4
Effect  of  a  applied voltage,  and b  extraction  time.  Extraction  conditions:
concentration  of  analytes,  1  mg  L ;  sample  pH,  4;  SLM,  DEHPi  with
25 mM TFPBA; applied voltage,  50 V (if  not  indicated);  extraction time,
10 min (if not indicated); acceptor solution, 20 mM formic acid. Error bars
represent the standard deviation of three replicated analysis
−1
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Finally, extraction time was investigated and the results are shown in Fig.
4b. Recoveries increased as a function of time during the first 15 min of
extraction, as expected. Longer extraction times did not improve extraction
recoveries and, according to previous publications, this effect could be
attributed to pH changes in the acceptor solution due to electrolysis [22,
28]. The extraction time effect was also evaluated in a real urine sample
diluted with 20 mM phosphate buffer pH 4 (volume ratio 1:1). As with the
aqueous samples, no improvement in recoveries was observed after 15 min
of extraction (data not shown). Therefore, 15 min was finally selected as
optimum time for complexation-mediated EME of the catecholamines.
Extraction performance in urine samples under
optimized conditions
The final EME system was based on the following optimized conditions:
SLM, DEHPi with 25 mM TFPBA; sample pH, 4; acceptor solution,
20 mM formic acid; applied voltage, 50 V; and extraction time, 15 min.
Under these conditions, recoveries were 10% for E, 15% for NE, and 29%
for DA when EME was performed from aqueous standards. However,
when analyzing urine samples, extraction recoveries decreased
significantly as discussed in “Evaluation” section.
EME is known to provide excellent sample clean-up since the SLM forms
a hydrophobic barrier between the sample and acceptor solution. Figure 5a
shows HPLC-UV chromatograms before and after complexation-mediated
EME of a diluted urine sample (volume ratio 1:1, urine/20 mM phosphate
buffer pH 4) at a 1 mg L  spiking level. Although some peaks from the
sample matrix are present after EME, differences between the two
chromatograms are obvious, indicating a high level of sample clean-up.
This indicated that even though the complexation reagent improved the
mass transfer of the highly polar model analytes across the SLM, the
selective nature of this complexation prevented the bulk matrix of the urine
sample from entering the SLM. Additionally, the system current profile is
illustrated in Fig. 5b, showing that the complexation-mediated EME
system was highly stable in contact with the diluted urine sample under
optimized conditions.
Fig. 5
EME performance in urine sample under optimized conditions: a HPLC-UV
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chromatograms showing sample clean-up, and b system current profile
Evaluation
Finally, the complexation-mediated EME concept was combined with
UHPLC-MS/MS and evaluated for quantification of E and DA. The main
purpose of this was to test if the new concept of complexation-mediated
EME can provide reliable data. A complete validation was not considered
at this stage. Quality analytical parameters were evaluated in pooled urine
from three healthy volunteers. Standard addition calibration was used due
to the matrix effects. To this end, pooled urine sample was diluted with
20 mM phosphate buffer of pH 4 (volume ratio 1:1) and calibration curves
were constructed using standards of five concentration levels from 25 to
125 µg L . The content of E in the pooled urine sample was under the
limit of detection (LOD) of the method whereas the content of DA was
under the limit of quantification (LOQ). Correlation coefficient values (r)
were 0.990 for E and 0.996 for DA. The Student’s t test was applied to
assess the linearity showing values of 11.91 (r = 0.990, N = 5) for E and to
8.20 (r = 0.996, N = 5) for DA, thus rejecting the null hypothesis of
−1
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non-linear correlation for a 5% significance level and 3 degrees of freedom
(t  = 3.18) [29]. The repeatability of the method, expressed as
coefficient of variation (CV), was determined by five consecutive
extractions from diluted pooled urine sample spiked at a concentration
level of 50 µg L . CV was 13% for both E and DA.
Extraction recoveries of the proposed procedure were found by the
following strategy. First, diluted pooled urine sample was spiked at
50 µg L  with E and DA and subjected to EME. Then, EME was
conducted from non-spiked diluted pooled urine and the final extract was
spiked at 50 µg L . Signals obtained in both experiments were compared
and, considering acceptor and sample solution volumes (i.e., 25 µL and
1 mL, respectively), extraction recoveries were calculated to (5.5 ± 0.9)%
for E and (15 ± 2)% for DA (n = 5). At this recovery level, LODs (S/N = 3)
were 5.0 and 1.8 µg L , and LOQs (S/N = 10) were 16.5 and 6.0 µg L
for E and DA, respectively. Enrichment factors were 2.2 for E and 6.0 for
DA. Although low enrichment factor were obtained, they could be further
improved increasing sample and acceptor phases volume ratios.
Finally, diluted pooled urine sample was spiked at a known concentration
level (i.e., 50 µg L ) and analyzed by standard addition calibration using
standards of five concentration levels from 25 to 125 µg L . Relative
recoveries were calculated as ratio between found and spiked
concentrations being (91 ± 26)% for E and (117 ± 20)% for DA, where
standard deviation values were calculated using the s  (i.e., standard
deviation of x-value estimated using regression line [29]).
Conclusions
In this work, complexation-mediated EME of highly polar basic drug
substances was demonstrated for the first time using selected
catecholamines as model analytes. Complexation in the bulk sample with
water-soluble PBA derivatives added to the sample, and complexation at
the sample/SLM interface with water-insoluble PBA derivatives added to
the SLM were tested, and the latter concept appeared to be most efficient.
Thus, complexation of the catecholamines with TFPBA at the sample/SLM
interface was found to enhance the mass transfer across the SLM. Because
the complexation reaction involved substances with two phenolic groups in
ortho position only, the reaction was selective and therefore complexation-
0.05,3
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mediated EME appeared to be selective even from biological fluids. Thus,
although the SLM permitted mass transfer of target analytes with −1 > log
P > −2, most bulk matrix components in human urine was unable to pass
the SLM, and acceptable sample clean-up was achieved. Additionally, the
current in the complexation-mediated EME system was easily controlled
and kept below 50 µA, and therefore the system provided acceptable
stability. The complexation-mediated EME concept was combined with
UHPLC-MS/MS to develop a model application. Although the work
presented in this paper is preliminary in nature, complexation-mediated
EME showed potential and extraction of basic drugs with log P in the
range −1 to −2 was demonstrated for the first time. Complexation-mediated
EME should be investigated in more detail in the future. With this concept,
analyte detection may be performed with instruments much more simple
than mass spectrometry (as used in this initial work), and this may open
new and very interesting future possibilities.
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